North America Congestive Heart Failure (CHF) Treatment Devices Market Size, 2028

North America Congestive Heart Failure (CHF) Treatment Devices Market Size, Share & Industry Trends Analysis Report By Product Type (Pacemakers, Implantable Cardioverter Defibrillators, Cardiac Resynchronization Therapy, and Ventricular Assist Devices), By Country and Growth Forecast, 2022 - 2028

Published Date: May-2022 | Number of Pages: 70 | Format: PDF | Report ID: KBV-18074

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Congestive Heart Failure (CHF) Treatment Devices Market, by Product Type
1.4.2 North America Congestive Heart Failure (CHF) Treatment Devices Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2018, Jul – 2022, Feb) Leading Players

Chapter 4. North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
4.1 North America Pacemakers Market by Country
4.2 North America Implantable Cardioverter Defibrillators Market by Country
4.3 North America Cardiac Resynchronization Therapy Market by Country
4.4 North America Ventricular Assist Devices Market by Country

Chapter 5. North America Congestive Heart Failure (CHF) Treatment Devices Market by Country
5.1 US Congestive Heart Failure (CHF) Treatment Devices Market
5.1.1 US Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.2 Canada Congestive Heart Failure (CHF) Treatment Devices Market
5.2.1 Canada Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.3 Mexico Congestive Heart Failure (CHF) Treatment Devices Market
5.3.1 Mexico Congestive Heart Failure (CHF) Treatment Devices Market by Product Type
5.4 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market
5.4.1 Rest of North America Congestive Heart Failure (CHF) Treatment Devices Market by Product Type

Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approvals and Trials:
6.1.5.2 Product Launches and Product Expansions:
6.1.5.3 Acquisition and Mergers:
6.2 MicroPort Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Approvals and Trials:
6.2.5.2 Product launches and Product Expansions:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Approvals and Trials:
6.3.5.3 Acquisitions and Mergers:
6.3.5.4 Product Launches and Product Expansions:
6.4 Medtronic PLC
6.4.1 Company overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.5 Abiomed, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals and Trials:
6.5.5.2 Acquisition and Mergers:
6.6 Berlin Heart GmbH
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Partnerships, Collaborations, and Agreements:
6.7 Jarvik Heart, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology (Beijing) Co., Ltd.
6.8.1 Company Overview
6.9 BIOTRONIK SE & Co. KG
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations and Agreements:
6.9.2.2 Approvals & Trials:
6.9.2.3 Product Launches and Product Expansions:
6.10. Osypka Medical GmbH
6.10.1 Company Overview

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities